comparemela.com
Home
Live Updates
HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders : comparemela.com
HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders
/PRNewswire/ -- HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced that it...
Related Keywords
China ,
Delaware ,
United States ,
Boston ,
Massachusetts ,
Boston University ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Michael Rosenblatt ,
Jingsong Wang ,
Robert Kamen ,
Philip Reilly ,
Asia Pacific ,
Frank Grosveld ,
Joseph Majzoub ,
Division Of Endocrinology ,
Leadership Advisory Team ,
Harvard Medical School ,
Alpha Therapeutics Hbmat Inc ,
University Of Cambridge ,
Overseer Weill Cornell Medical College ,
Genetics Institute Inc ,
Unit Head Of Abbott Bioresearch Centre ,
Department Of Pediatrics ,
Harbour Biomed ,
Boston Children ,
Scientific Advisory Board ,
Advisory Board ,
Harbour Antibodies ,
Cushing Syndrome ,
Harvard Medical ,
Translational Medicine ,
Vice Chair ,
Boston University School ,
Save Children ,
Rare Genetic ,
Harvard Medical School Board ,
Massachusetts General Hospital ,
Chief Medical Officer ,
Third Rock ,
Neon Therapeutics ,
Unit Head ,
Abbott Bioresearch Centre ,
Genetics Institute ,
Hbm Alpha Therapeutics ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Biotechnology ,
Venture Capital ,
comparemela.com © 2020. All Rights Reserved.